Aytu BioPharma, Inc. (AYTU) Stock
Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks
Aytu BioPharma, Inc. (AYTU) closed at USD 1.95 on 2026-10-14, a change of -10.1 % over the past year, with a market capitalization of USD 21.84M.
Aytu BioPharma, Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 1.95 |
| 2026-10-13 | 1.99 |
| 2026-10-12 | 1.97 |
| 2026-10-09 | 2.03 |
| 2026-10-08 | 2.05 |
| 2026-10-07 | 2.05 |
| 2026-10-06 | 2.05 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Aytu BioPharma, Inc. key figures
- Previous close
- USD 1.95 (2026-10-14)
- 1-year change
- -10.1 %
- Market cap
- USD 21.84M
- Enterprise value
- USD 13.64M
- P/E ratio (trailing)
- -1.75
- P/E ratio (forward)
- 12.97
- EPS (trailing)
- -1.15
- EPS (forward)
- 0.16
- PEG ratio
- n/a
- Price to book
- 0.61
- Revenue growth
- 6.4 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 7.10
- Employees
- 75
- Analyst consensus (third-party)
- strong_buy
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Aytu BioPharma, Inc.
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT A central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 17 years of age; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 15 years of age. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Aytu BioPharma, Inc. and compare it with other stocks.
Analyze AYTUAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Aytu BioPharma, Inc. shares.